Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > AUA Poster Session

<< Previous

Bullboard Posts

Next >>

Comment by tdon1229on Apr 12, 2023 12:39pm

125 Views

Post# 35390953

RE:RE:RE:RE:RE:RE:AUA Poster Session

AUA presentation is a moderated poster presentation ... lots of opportunity for a useful shill among the attendees to ask for a data update and for the presentor to rattle off the new numbers before the moderator cuts him off ... IMHO, that is.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023